5 alpha-reductase inhibitors in prostate cancer

被引：15

作者：

Gormley, GJ

机构：

[1] Clin. Res. Endocrinol./Metabolism, Merck and Co Inc., Rahway, NJ 07065-0914

来源：

关键词：

D O I：

10.1677/erc.0.0030057

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：57 / 63

页数：7

共 35 条

[1] STRUCTURAL AND BIOCHEMICAL-PROPERTIES OF CLONED AND EXPRESSED HUMAN AND RAT STEROID 5-ALPHA-REDUCTASES [J].

ANDERSSON, S ;

RUSSELL, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3640-3644

[2]

ANDERSSON S, 1989, J BIOL CHEM, V264, P16249

[3] TREATMENT WITH FINASTERIDE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER [J].

ANDRIOLE, G ;

LIEBER, M ;

SMITH, J ;

SOLOWAY, M ;

SCHROEDER, F ;

KADMON, D ;

DEKERNION, J ;

RAJFER, J ;

BOAKE, R ;

CRAWFORD, D ;

RAMSEY, E ;

PERREAULT, J ;

TRACHTENBERG, J ;

FRADET, T ;

BLOCK, N ;

MIDDLETON, R ;

NG, J ;

FERGUSON, D ;

GORMLEY, G .

UROLOGY, 1995, 45 (03) :491-497

[4]

BOLOGNA M, 1992, CURR THER RES CLIN E, V51, P799

[5] FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO [J].

BOLOGNA, M ;

MUZI, P ;

BIORDI, L ;

FESTUCCIA, C ;

VICENTINI, C .

UROLOGY, 1995, 45 (02) :282-290

[6] CANCER STATISTICS, 1992 [J].

BORING, CC ;

SQUIRES, TS ;

TONG, T .

CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (01) :19-38

[7] EFFECT OF CASTRATION, DES, FLUTAMIDE, AND THE 5-ALPHA-REDUCTASE INHIBITOR, MK-906, ON THE GROWTH OF THE DUNNING RAT PROSTATIC-CARCINOMA, R-3327 [J].

BROOKS, JR ;

BERMAN, C ;

NGUYEN, H ;

PRAHALADA, S ;

PRIMKA, RL ;

RASMUSSON, GH ;

SLATER, EE .

PROSTATE, 1991, 18 (03) :215-227

[8] HAIR-GROWTH EFFECTS OF ORAL-ADMINISTRATION OF FINASTERIDE, A STEROID 5-ALPHA-REDUCTASE INHIBITOR, ALONE AND IN COMBINATION WITH TOPICAL MINOXIDIL IN THE BALDING STUMPTAIL MACAQUE [J].

DIANI, AR ;

MULHOLLAND, MJ ;

SHULL, KL ;

KUBICEK, MF ;

JOHNSON, GA ;

SCHOSTAREZ, HJ ;

BRUNDEN, MN ;

BUHL, AE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (02) :345-350

[9] DESIGN OF THE PROSTATE-CANCER PREVENTION TRIAL (PCPT) [J].

FEIGL, P ;

BLUMENSTEIN, B ;

THOMPSON, I ;

CROWLEY, J ;

WOLF, M ;

KRAMER, BS ;

COLTMAN, CA ;

BRAWLEY, OW ;

FORD, LG .

CONTROLLED CLINICAL TRIALS, 1995, 16 (03) :150-163

[10]

FLESHNER NE, 1993, EUR UROL, V24, P106

← 1 2 3 4 →